Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

NCT05453916 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG: Nitazoxanide 500Mg Oral Tablet
DRUG: Rifaximin 550Mg Tab

Sponsor

Sadat City University